Layer, Chiang, et al. Genome Biology
Access Aims to Develop Oral Drug-Delivery Technology for RNAi Therapeutics
The technology, dubbed Cobalamin, is based on the body's natural vitamin B12 uptake mechanism, and involves merging a polymer and active pharmaceutical ingredient to make a nanoparticle, which is then coated with the vitamin.
New to GenomeWeb? Register here quickly.